Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related RNA
State Of The Union Lights Up Biotech
Benzinga's Top Downgrades
Related
Market Panic Has Created 'Compelling' Opportunities In Biotech
Piper Jaffray Goes Overweight Sarepta, Expects FDA To Accept Next Key Drug Filing

Prosensa Holding NV (NASDAQ: RNA) dipped 74.54% to $6.11 in the pre-market session on failed duchenne muscular dystrophy study.

AK Steel Holding (NYSE: AKS) shares fell 10.59% to $3.97 in the pre-market trading after the company projected wider loss for the third quarter.

Sarepta Therapeutics (NASDAQ: SRPT) shares dropped 8.69% to $33.50 in pre-market trading on GlaxoSmithKline (NYSE: GSK) trial miss.

Darden Restaurants (NYSE: DRI) dipped 5.48% to $46.60 in the pre-market session after the company reported downbeat Q1 results and announced the retirement of its COO.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (AKS + DRI)

View Comments and Join the Discussion!

Get Benzinga's Newsletters